» Articles » PMID: 36145212

Sex Difference in the Associations Among Hyperuricemia with New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study

Overview
Journal Nutrients
Date 2022 Sep 23
PMID 36145212
Authors
Affiliations
Soon will be listed here.
Abstract

The global prevalence and incidence of chronic kidney disease (CKD) continue to increase. Whether hyperuricemia is an independent risk factor for renal progression and whether there are sex differences in the relationships between serum uric acid (UA) and a decline in renal function are unclear. Therefore, in this longitudinal study, we aimed to explore these relationships in a large cohort of around 27,000 Taiwanese participants in the Taiwan Biobank (TWB), and also to identify serum UA cutoff levels in men and women to predict new-onset CKD. A total of 26,942 participants with a median 4 years of complete follow-up data were enrolled from the TWB. We excluded those with CKD (estimated glomerular filtration rate <60 mL/min/1.73 m2) at baseline (n = 297), and the remaining 26,645 participants (males: 9356; females: 17,289) were analyzed. The participants who developed CKD during follow-up were defined as having incident new-onset CKD, and those with a serum UA level >7 mg/dL in males and >6 mg/dL in females were classified as having hyperuricemia. After multivariable analysis, hyperuricemia (odds ratio [OR], 2.541; 95% confidence interval [CI], 1.970−3.276; p < 0.001) was significantly associated with new-onset CKD. Furthermore, in the male participants (n = 9356), hyperuricemia (OR, 1.989; 95% CI, 1.440−2.747; p < 0.001), and quartile 4 of UA (vs. quartile 1; OR, 2.279; 95% CI, 1.464−3.547; p < 0.001) were significantly associated with new-onset CKD, while in the female participants (n = 17,289), hyperuricemia (OR, 3.813; 95% CI, 2.500−5.815; p < 0.001), quartile 3 of UA (vs. quartile 1; OR, 3.741; 95% CI, 1.250−11.915; p = 0.018), and quartile 4 of UA (vs. quartile 1; OR, 12.114; 95% CI, 14.278−34.305; p < 0.001) were significantly associated with new-onset CKD. There were significant interactions between hyperuricemia and sex (p = 0.024), and quartiles of serum UA and sex (p = 0.010) on new-onset CKD. Hyperuricemia was associated with new-onset CKD in the enrolled participants, and the interactions between hyperuricemia and sex were statistically significant. Hyperuricemia was more strongly associated with new-onset CKD in the women than in the men.

Citing Articles

Sex difference in the risk of coronary artery calcification progression related to hyperuricemia among asymptomatic 12,316 Korean adults.

Won K, Choi S, Chun E, Park S, Sung J, Jung H Sci Rep. 2024; 14(1):28710.

PMID: 39567626 PMC: 11579511. DOI: 10.1038/s41598-024-80324-2.


Gender Influence on XOR Activities and Related Pathologies: A Narrative Review.

Bolognesi A, Bortolotti M, Battelli M, Polito L Antioxidants (Basel). 2024; 13(2).

PMID: 38397809 PMC: 10885918. DOI: 10.3390/antiox13020211.


Insufficient compensatory pancreatic β-cells function might be closely associated with hyperuricemia in U.S. adults: evidence from the National Health and Nutrition Examination Survey.

Shen T, Zheng Q, Zhong L, Zeng X, Yuan X, Mo F BMC Public Health. 2024; 24(1):85.

PMID: 38172728 PMC: 10765924. DOI: 10.1186/s12889-023-17471-0.


Elevated Uric Acid Levels with Early Chronic Kidney Disease as an Indicator of New-Onset Ischemic Heart Disease: A Cohort of Koreans without Diabetes.

Lee S, Lee H, Ryu H, Park B, Jung D Biomedicines. 2023; 11(8).

PMID: 37626709 PMC: 10452705. DOI: 10.3390/biomedicines11082212.


Serum uric acid is associated with chronic kidney disease in elderly Chinese patients with diabetes.

Zhou Q, Ke S, Yan Y, Guo Y, Liu Q Ren Fail. 2023; 45(1):2238825.

PMID: 37488934 PMC: 10599260. DOI: 10.1080/0886022X.2023.2238825.


References
1.
Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P . The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh). 1977; 85(1):198-208. DOI: 10.1530/acta.0.0850198. View

2.
Muntner P, Coresh J, Smith J, Eckfeldt J, Klag M . Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000; 58(1):293-301. DOI: 10.1046/j.1523-1755.2000.00165.x. View

3.
Sanchez-Lozada L, Soto V, Tapia E, Avila-Casado C, Sautin Y, Nakagawa T . Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008; 295(4):F1134-41. PMC: 2576157. DOI: 10.1152/ajprenal.00104.2008. View

4.
Liu W, Hung C, Chen S, Yeh S, Lin M, Chiu Y . Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012; 7(4):541-8. DOI: 10.2215/CJN.09420911. View

5.
Chen T, Knicely D, Grams M . Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019; 322(13):1294-1304. PMC: 7015670. DOI: 10.1001/jama.2019.14745. View